Cargando…

Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C

BACKGROUND: IL28B gene polymorphism is the best baseline predictor of response to interferon alfa-based antiviral therapies in chronic hepatitis C. Recently, a new IFN-L4 polymorphism was identified as first potential functional variant for induction of IL28B expression. Individualization of interfe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Susser, Simone, Herrmann, Eva, Lange, Christian, Hamdi, Nabila, Müller, Tobias, Berg, Thomas, Perner, Dany, Zeuzem, Stefan, Sarrazin, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231027/ https://www.ncbi.nlm.nih.gov/pubmed/25393304 http://dx.doi.org/10.1371/journal.pone.0112592

Ejemplares similares

Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients
por: Dietz, Julia, et al.
Publicado: (2015)

Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes
por: Chaturvedi, Nimisha, et al.
Publicado: (2019)

Soluble Serum CD81 Is Elevated in Patients with Chronic Hepatitis C and Correlates with Alanine Aminotransferase Serum Activity
por: Welker, Martin-Walter, et al.
Publicado: (2012)

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy
por: Dietz, Julia, et al.
Publicado: (2016)

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting
por: Wiegand, Steffen B., et al.
Publicado: (2015)

Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection
por: Fischer, Janett, et al.
Publicado: (2013)

A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers
por: Vermehren, Johannes, et al.
Publicado: (2012)

The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C
por: Bellanti, F., et al.
Publicado: (2012)

Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus
por: Welsch, Christoph, et al.
Publicado: (2008)

The Correlation Between Interferon Lambda 3 Gene Polymorphisms and Susceptibility to Hepatitis B Virus Infection
por: Heidari, Zahra, et al.
Publicado: (2016)

Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C
por: Wróblewska, Anna, et al.
Publicado: (2016)

The Role of Interferon Lambda 3 Genetic Polymorphisms in Response to Interferon Therapy in Chronic Hepatitis B Patients: An Updated Meta-Analysis
por: Lin, Zhifeng, et al.
Publicado: (2016)

Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C Infection
por: Solbach, Philipp, et al.
Publicado: (2015)

Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infection
por: de Bitencorte, Jóice Teixeira, et al.
Publicado: (2021)

A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C
por: Lange, Christian M., et al.
Publicado: (2012)

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients
por: Phillips, Sandra, et al.
Publicado: (2017)

Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic Immunity
por: Rueschenbaum, Sabrina, et al.
Publicado: (2021)

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
por: Ansari, M Azim, et al.
Publicado: (2019)

Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies
por: Novotny, Laura A., et al.
Publicado: (2021)

The Impact of interferon lambda 3 Polymorphism on Hepato-Cellular Carcinoma Progression in Hepatitis C Virus Patients: Treatment-Naïve and Experienced
por: Abd Elrahman, Mohamed, et al.
Publicado: (2023)

Interferon lambdas: the next cytokine storm
por: Kelly, Christabel, et al.
Publicado: (2011)

Genetics of the Human Interferon Lambda Region
por: Prokunina-Olsson, Ludmila
Publicado: (2019)

Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma
por: Nukui, Akinori, et al.
Publicado: (2017)

A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages
por: Bamford, Connor G. G., et al.
Publicado: (2018)

Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
por: Welsch, Christoph, et al.
Publicado: (2017)

PEG-IFN Alpha but Not Ribavirin Alters NK Cell Phenotype and Function in Patients with Chronic Hepatitis C
por: Markova, Antoaneta A., et al.
Publicado: (2014)

Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha
por: da Silva, Andréa Marques Vieira, et al.
Publicado: (2021)

Treatment induced clearance of hepatitis E viruses by interferon‐lambda in liver‐humanized mice
por: Sari, Gulce, et al.
Publicado: (2021)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
por: Friedrich-Rust, Mireen, et al.
Publicado: (2010)

Lambda Interferons: New Cytokines with Old Functions
por: Hamming, Ole J., et al.
Publicado: (2010)

Interferon Lambda: Modulating Immunity in Infectious Diseases
por: Syedbasha, Mohammedyaseen, et al.
Publicado: (2017)

Macrophage Coordination of the Interferon Lambda Immune Response
por: Read, Scott A., et al.
Publicado: (2019)

Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases
por: Wallace, Jonathan W., et al.
Publicado: (2021)

Interferon lambda in inflammation and autoimmune rheumatic diseases
por: Goel, Rishi R., et al.
Publicado: (2021)

Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study
por: Grzegorzewska, Alicja E., et al.
Publicado: (2021)

Interferon-lambda mediates resistance against various respiratory viruses
por: Markus, Mordstein, et al.
Publicado: (2009)

Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C
por: Ramamurthy, Narayan, et al.
Publicado: (2018)

Multi-ancestry Fine Mapping of Interferon Lambda and the Outcome of Acute Hepatitis C Virus Infection
por: Vergara, Candelaria, et al.
Publicado: (2020)

Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
por: Chen, Qian, et al.
Publicado: (2021)

Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients
por: Grammatikos, Georgios, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0to72t33k4ke9edhb877tne0sm